Clinical trials

  • BERUBICIN HYDROCHLORIDE for Primary central nervous system lymphoma|Non-Hodgkin lymphoma with CNS involvement
  • RANIBIZUMAB for Neovascular age-related macular degeneration
  • ALDESLEUKIN for Pancreatic cancer
  • N-[4-({[(1R,4R)-4-HYDROXY-4-METHYLCYCLOHEXYL]METHYL}AMINO)-3-NITROBENZENE-1-SULFONYL]-4-(2-{(2S)-2-[2-(PROPAN-2-YL)PHENYL]PYRROLIDIN1-YL}-7-AZASPIRO[3.5]NONAN-7-YL)-2-[(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)OXY]BENZAMIDE for Previously Untreated Chronic Lymphocytic Leukemia | Chronic lymphocytic leukemia
  • somapacitan for Short stature | Small for gestational age (SGA) | Turner syndrome | Noonan syndrome | Idiopathic short stature (ISS)
  • RIFAMYCIN SODIUM for Left-sided ulcerative colitis | Ulcerative proctitis
  • GLOFITAMAB for Diffuse large B-cell lymphoma | Relapsed/refractory diffuse large B-cell lymphoma
  • INTESTIFIX for Hepatocellular carcinoma|Non-resectable hepatocellular carcinoma
  • alectinib for ALK-positive non-small cell lung cancer
  • pembrolizumab for Melanoma|Malignant melanoma stage II|Malignant melanoma stage III
  • ZILTIVEKIMAB for Acute myocardial infarction (type 1)
  • Etentamig (ABBV-383) for Relapsed/Refractory Multiple Myeloma